Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 26, 2021 Filed Jul 28, 2021 13:11 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 103 | $15.30 | $1,575.90 |
DisclosureSEC source: 0001209191-21-048398 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,821 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 13:11 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-048398 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 13:41 UTC |
Holden StuartDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-039130 · doc4.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:45 UTC |
Cohen Fred EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-039136 · doc4.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:44 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-039135 · doc4.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:43 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-039134 · doc4.xml · derivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:43 UTC |
Tomasello ShawnDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-039133 · doc4.xml · derivative · entry 1 Tomasello Shawn · CIK 0001617239 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:42 UTC |
Nussbaum RanDirector
|
GrantStock Option (right to buy) · Derivative | 3,183 | $0.00 Strike: $17.89 | $0.00 |
DisclosureSEC source: 0001209191-21-039132 · doc4.xml · derivative · entry 4 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 3,183 Underlying: Common Stock · 3,183 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:42 UTC |
Nussbaum RanDirector
|
GrantStock Option (right to buy) · Derivative | 6,817 | $0.00 Strike: $17.89 | $0.00 |
DisclosureSEC source: 0001209191-21-039132 · doc4.xml · derivative · entry 3 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Pontifax (Israel) III Limited Partnership Disclosed balance after: 6,817 Underlying: Common Stock · 6,817 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:41 UTC |
Belldegrun ArieDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-039131 · doc4.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 18:33 UTC |
Smith Jason DrewGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-038842 · doc4.xml · derivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-05-31 F1 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of June 1, 2022, June 1, 2023 and June 1, 2024. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 18:33 UTC |
Henderson MollyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $17.98 | $0.00 |
DisclosureSEC source: 0001209191-21-038841 · doc4.xml · derivative · entry 1 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-05-31 F1 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of June 1, 2022, June 1, 2023 and June 1, 2024. Read SEC document |
| May 19, 2021 Filed May 21, 2021 17:44 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Tax withholdingOrdinary Shares | 1,240 | $17.51 | $21,711.04 |
DisclosureSEC source: 0001209191-21-034823 · doc4.xml · nonDerivative · entry 4 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,499 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs. Read SEC document |
| May 19, 2021 Filed May 21, 2021 17:44 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Tax withholdingOrdinary Shares | 2,185 | $17.51 | $38,256.95 |
DisclosureSEC source: 0001209191-21-034823 · doc4.xml · nonDerivative · entry 3 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,739 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs. Read SEC document |
| May 17, 2021 Filed May 18, 2021 15:36 UTC |
Henderson MollyChief Financial Officer
|
PurchaseCommon Stock | 2,500 | $15.85 | $39,625.00 |
DisclosureSEC source: 0001209191-21-033402 · doc4.xml · nonDerivative · entry 1 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| May 17, 2021 Filed May 18, 2021 15:35 UTC |
Smith Jason DrewGeneral Counsel
|
PurchaseCommon Stock | 2,500 | $15.71 | $39,275.00 |
DisclosureSEC source: 0001209191-21-033399 · doc4.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675 and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:58 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029758 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:58 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 243 | $20.00 | $4,860.00 |
DisclosureSEC source: 0001209191-21-029758 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,132 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:58 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-029758 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 17:44 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028500 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Underlying: Ordinary Shares · 209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 17:44 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 89 | $19.63 | $1,747.07 |
DisclosureSEC source: 0001209191-21-028500 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,875 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 17:44 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-028500 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| March 26, 2021 Filed Jun 9, 2021 17:47 UTC Amendment |
Belldegrun ArieDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,241 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039138 · doc4a.xml · derivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,241 shares Expires 2021-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021. Read SEC document |
| March 26, 2021 Filed Jun 9, 2021 17:47 UTC Amendment |
Belldegrun ArieDirector
|
Exercise / conversionOrdinary Shares | 3,241 | $5.00 | $16,205.00 |
DisclosureSEC source: 0001209191-21-039138 · doc4a.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021. Read SEC document |
| March 25, 2021 Filed Jun 9, 2021 17:46 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,030 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039137 · doc4a.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 1,030 shares Expires 2021-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021. Read SEC document |
| March 25, 2021 Filed Jun 9, 2021 17:46 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 1,030 | $5.00 | $5,150.00 |
DisclosureSEC source: 0001209191-21-039137 · doc4a.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing Partner of entities affiliated with Pontifax Management III G.P. ( Disclosed balance after: 1,431,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021. Read SEC document |
| March 25, 2021 Filed Jun 9, 2021 17:42 UTC |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,211 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039132 · doc4.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Pontifax (Israel) III Limited Partnership Disclosed balance after: 0 Underlying: Common Stock · 2,211 shares Expires 2021-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2021 Filed Jun 9, 2021 17:42 UTC |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 2,211 | $5.00 | $11,055.00 |
DisclosureSEC source: 0001209191-21-039132 · doc4.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing Partner of entities affiliated with Pontifax Management III G.P. Disclosed balance after: 1,433,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Apr 22, 2021 21:19 UTC |
Belldegrun ArieDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,241 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027978 · doc4.xml · derivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,241 shares Expires 2021-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Apr 22, 2021 21:19 UTC |
Belldegrun ArieDirector
|
Exercise / conversionOrdinary Shares | 3,241 | $5.00 | $16,205.00 |
DisclosureSEC source: 0001209191-21-027978 · doc4.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Apr 22, 2021 21:18 UTC |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,030 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027977 · doc4.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 1,030 shares Expires 2021-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Apr 22, 2021 21:18 UTC |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 1,030 | $5.00 | $5,150.00 |
DisclosureSEC source: 0001209191-21-027977 · doc4.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing Partner of entities affiliated with Pontifax Management III G.P. ( Disclosed balance after: 1,465,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:53 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006699 · doc4.xml · derivative · entry 5 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024 F5 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024 Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:53 UTC |
Schoenberg MarkChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $22.07 | $0.00 |
DisclosureSEC source: 0001209191-21-006699 · doc4.xml · derivative · entry 4 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Ordinary Shares · 21,000 shares Expires 2031-01-31 F4 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024 Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:53 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006699 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:53 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,076 | $22.07 | $23,747.32 |
DisclosureSEC source: 0001209191-21-006699 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,755 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:53 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-006699 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 20:57 UTC |
Henderson MollyChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006710 · doc4.xml · derivative · entry 2 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. F3 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 20:57 UTC |
Henderson MollyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $22.07 | $0.00 |
DisclosureSEC source: 0001209191-21-006710 · doc4.xml · derivative · entry 1 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-01-30 F1 · derivative.exercise_date: 1/3 of the shares underlying the stock option will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 20:55 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006709 · doc4.xml · derivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. F3 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 20:55 UTC |
Smith Jason DrewGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $22.07 | $0.00 |
DisclosureSEC source: 0001209191-21-006709 · doc4.xml · derivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires 2031-01-30 F1 · derivative.exercise_date: 1/3 of the shares underlying the stock option will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:54 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006700 · doc4.xml · derivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024 F3 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024 Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 19:54 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $22.07 | $0.00 |
DisclosureSEC source: 0001209191-21-006700 · doc4.xml · derivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires 2031-01-31 F1 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024 Read SEC document |
| January 31, 2021 Filed May 21, 2021 17:44 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034823 · doc4.xml · derivative · entry 6 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021. Read SEC document |
| January 31, 2021 Filed May 21, 2021 17:44 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-034823 · doc4.xml · nonDerivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 26, 2021 Filed Jan 26, 2021 22:20 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-005460 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834 Underlying: Ordinary Shares · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| January 26, 2021 Filed Jan 26, 2021 22:20 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 100 | $22.12 | $2,212.00 |
DisclosureSEC source: 0001209191-21-005460 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,831 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 26, 2021 Filed Jan 26, 2021 22:20 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-005460 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 03, 2021 Filed May 21, 2021 17:44 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034823 · doc4.xml · derivative · entry 5 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,689 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs will vest on January 3, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs will vest on January 3, 2022. Read SEC document |
| January 03, 2021 Filed May 21, 2021 17:44 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-034823 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.